Ignite Creation Date:
2025-12-26 @ 10:16 PM
Ignite Modification Date:
2026-03-08 @ 11:20 PM
Study NCT ID:
NCT02396212
Status:
COMPLETED
Last Update Posted:
2019-09-13
First Post:
2015-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Systemic Juvenile Idiopathic Arthritis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | ACZ885 | View |
| None | canakinumab | View |
| None | Juvenile Rheumatoid arthritis (JRA) chronic | View |
| None | systemic inflammatory disorder | View |
| None | painful joints | View |
| None | inflammation of the synovial membrane | View |
| None | auto-immune rheumatoid disease | View |
| None | reactive rheumatoid arthritis | View |
| None | Systemic Juvenile Rheumatoid arthritis (SJRA) | View |
| None | Japanese patients | View |